The cholinergic anti-inflammatory pathway ameliorates acute viral myocarditis in mice by regulating CD4⁺ T cell differentiation

References

• Fairweather D, Rose NR. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods. 2007;41:118–122.
   PubMed Web of Science ®Google Scholar
• Kania G, Siegert S, Behnke S, et al. Innate signaling promotes formation of regulatory nitric oxide-producing dendritic cells limiting T-cell expansion in experimental autoimmune myocarditis. Circulation. 2013;127:2285–2294.
   PubMed Web of Science ®Google Scholar
• Huber SA, Pfaeffle B. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J Virol. 1994;68:5126–5132.
   PubMed Web of Science ®Google Scholar
• Rangachari M, Mauermann N, Marty RR, et al. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med. 2006;203:2009–2019.
   PubMed Web of Science ®Google Scholar
• Huber SA, Feldman AM, Sartini D. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice. Circ Res. 2006;99:1109–1116.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Li-Sha G, Jing-Lin Z, et al. Protective role of the cholinergic anti-inflammatory pathway in a mouse model of viral myocarditis. PLoS One. 2014;9:e112719.
   PubMed Web of Science ®Google Scholar
• Li-Sha G, Jing-Lin Z, Guang-Yi C, et al. Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3. Sci Rep. 2015;5:15895.
   PubMed Web of Science ®Google Scholar
• Li-Sha G, Jing-Lin Z, Li L, et al. Nicotine inhibits the production of proinflammatory cytokines of mice infected with coxsackievirus B3. Life Sci. 2016;148:9–16.
   PubMed Web of Science ®Google Scholar
• Li-Sha G, Xing-Xing C, Lian-Pin W, et al. Right cervical vagotomy aggravates viral myocarditis in mice via the cholinergic anti-inflammatory pathway. Front Pharmacol. 2017;8:25.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Li-Sha G, Yue-Chun L. Autonomic nervous system in viral myocarditis: pathophysiology and therapy. Curr Pharm Des. 2016;22:485–498.
   PubMed Web of Science ®Google Scholar
• Galitovskiy V, Qian J, Chernyavsky AI, et al. Cytokine-induced alterations of alpha7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis. J Immunol. 2011;187:2677–2687.
   PubMed Web of Science ®Google Scholar
• Leib C, Goser S, Luthje D, et al. Role of the cholinergic antiinflammatory pathway in murine autoimmune myocarditis. Circ Res. 2011;109:130–140.
   PubMed Web of Science ®Google Scholar
• Sun B, Zhang Y. Overview of orchestration of CD4+ T cell subsets in immune responses. Adv Exp Med Biol. 2014;841:1–13.
   PubMed Web of Science ®Google Scholar
• Tracey KJ. The inflammatory reflex. Nature. 2002;420:853–859.
   PubMed Web of Science ®Google Scholar
• The FO, Boeckxstaens GE, Snoek SA, et al. Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice. Gastroenterology. 2007;133:1219–1228.
   PubMed Web of Science ®Google Scholar
• Wu S, Luo H, Xiao X, et al. Attenuation of collagen induced arthritis via suppression on Th17 response by activating cholinergic anti-inflammatory pathway with nicotine. Eur J Pharmacol. 2014;735:97–104.
   PubMed Web of Science ®Google Scholar
• Nizri E, Irony-Tur-Sinai M, Lory O, et al. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol. 2009;183:6681–6688.
   PubMed Web of Science ®Google Scholar
• Huber S. T cells in coxsackievirus-induced myocarditis. Viral Immunol. 2004;17:152–164.
   PubMed Web of Science ®Google Scholar
• Yamashita T, Iwakura T, Matsui K, et al. IL-6-mediated Th17 differentiation through RORgammat is essential for the initiation of experimental autoimmune myocarditis. Cardiovasc Res. 2011;91:640–648.
   PubMed Web of Science ®Google Scholar
• Yang F, Wu WF, Yan YL, et al. Expression of IL-23/Th17 pathway in a murine model of Coxsackie virus B3-induced viral myocarditis. Virol J. 2011;8:301.
   PubMed Web of Science ®Google Scholar
• Zhu H, Lou C, Liu P. Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells. Virol J. 2015;12:189.
   PubMed Web of Science ®Google Scholar
• Huber SA. Increased susceptibility of male BALB/c mice to coxsackievirus B3-induced myocarditis: role for CD1d. Med Microbiol Immunol. 2005;194:121–127.
   PubMed Web of Science ®Google Scholar
• Su N, Yue Y, Xiong S. Monocytic myeloid-derived suppressor cells from females, but not males, alleviate CVB3-induced myocarditis by increasing regulatory and CD4(+)IL-10(+) T cells. Sci Rep. 2016;6:22658.
   PubMed Web of Science ®Google Scholar
• Abston ED, Coronado MJ, Bucek A, et al. Th2 regulation of viral myocarditis in mice: different roles for TLR3 versus TRIF in progression to chronic disease. Clin Dev Immunol. 2012;2012:129486.
   PubMedGoogle Scholar
• Papageorgiou AP, Swinnen M, Vanhoutte D, et al. Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells. Cardiovasc Res. 2012;94:115–124.
   PubMed Web of Science ®Google Scholar
• Yu Z, Huang Z, Shao C, et al. Oral administration of interferon-alpha2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis. Virol J. 2011;8:525.
   PubMed Web of Science ®Google Scholar
• Wang YX, Da Cunha V, Vincelette J, et al. Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice. Am J Physiol Heart Circ Physiol. 2007;293:H69–76.
   PubMed Web of Science ®Google Scholar
• Yue Y, Gui J, Ai W, et al. Direct gene transfer with IP-10 mutant ameliorates mouse CVB3-induced myocarditis by blunting Th1 immune responses. PLoS One. 2011;6:e18186.
   PubMed Web of Science ®Google Scholar
• Yue Y, Gui J, Xu W, et al. Gene therapy with CCL2 (MCP-1) mutant protects CVB3-induced myocarditis by compromising Th1 polarization. Mol Immunol. 2011;48:706–713.
   PubMed Web of Science ®Google Scholar
• Gauntt C, Huber S. Coxsackievirus experimental heart diseases. Front Biosci. 2003;8:e23–35.
   PubMed Web of Science ®Google Scholar
• Yue-Chun L, Li-Sha G, Jiang-Hua R, et al. Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. J Cardiovasc Pharmacol. 2008;51:92–98.
   PubMed Web of Science ®Google Scholar